Ashley Hinson sold Heron Therapeuti (NASDAQ: HRTX)
Ashley Hinson (R-IA), a U.S. Representative, has disclosed 1 trade in Heron Therapeuti (HRTX) since 2021, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ashley Hinson sold $1,001 - $15,000 of Heron Therapeuti (NASDAQ: HRTX) on March 31, 2021. Since that trade, HRTX is down -97.35% against the S&P 500 up +103.11%, an outperformance of -200.46%.
Data updated
Ashley Hinson's HRTX trades vs the price
HRTX is down -97.35% since Ashley Hinson sold on March 31, 2021, versus +103.11% for the S&P 500.
Performance since this trade
All Ashley Hinson HRTX trades
Ashley Hinson & HRTX trading FAQ
Is it legal for Ashley Hinson to trade Heron Therapeuti (HRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Heron Therapeuti (HRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ashley Hinson sell HRTX?
Ashley Hinson disclosed a sale of $1,001 - $15,000 of Heron Therapeuti (HRTX) on March 31, 2021, according to public STOCK Act filings.
How has HRTX performed since Ashley Hinson's trade?
Since Ashley Hinson sold HRTX on March 31, 2021, the stock is down -97.35%, versus +103.11% for the S&P 500 over the same period, an outperformance of -200.46%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional HRTX trades?
Quantellect tracks every disclosed congressional trade in Heron Therapeuti (HRTX) on the Heron Therapeuti congressional trading page, which aggregates filings across all members of Congress.
Ashley Hinson's HRTX tradesAll congressional filings for Heron TherapeutiAshley Hinson's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.